Robot-assisted gait training to reduce pusher behavior: A randomized controlled trial.
Jeannine Bergmann, Carmen Krewer, Klaus Jahn...
https://pubmed.ncbi.nlm.nih.gov/30171076/Actively Recruiting
Led by University Hospital, Grenoble · Updated on 2026-09-01
3
Participants Needed
2
Research Sites
8 weeks
Total Duration
Lateropulsion is a condition where a persons body orientation is tilted sideways relative to the vertical plane, often occurring after a stroke and leading to balance and walking difficulties. This study is focused on individuals who have had a first ischemic right hemisphere stroke and show moderate to severe lateropulsion, caused by a biased internal sense of verticality. The goal is to test whether a specific rehabilitation program can improve their perception of verticality and reduce lateropulsion. The rehabilitation program being evaluated lasts three weeks and includes 15 sessions of 30 minutes each. These sessions combine specialized physiotherapy exercises focused on vertical body orientation with exoskeleton-assisted balance and gait exercises using the Atalante device. Participants also continue conventional physiotherapy, occupational therapy, and other usual care throughout the study. The program aims to recalibrate the internal model of verticality through exercises such as standing, stepping, and walking in different directions, with or without visual cues, as well as tasks to increase body tilt awareness. Participants will be involved in daily visual verticality assessments and weekly evaluations of postural verticality, lateropulsion severity, balance, gait, and motor function over an eight-week period. Data on patient comfort and satisfaction with the exoskeleton sessions will also be collected. The study includes three participants who begin the intervention at staggered weeks to monitor progress and control for unrelated changes. The study aims to support improved balance and mobility recovery after stroke through this focused rehabilitation approach.
CONDITIONS
Rehabilitation Program Dedicated to Post-stroke Lateropulsion Including Exoskeleton Assisted Exercises
D
Dominic Pérennou, MD, PhD, Pr
E
Eugénie Lhommée, MPsych
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital, Grenoble
Lead Sponsor
Fondation pour la recherche sur les AVC
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Daily visual vertical assessments except weekends; weekly control measures
Duration - 3 weeks
Participants receive a 3-week rehabilitation program including 15 sessions of exoskeleton-assisted and specific physiotherapy exercises focused on vertical body orientation, along with conventional physiotherapy and occupational therapy.
5 sessions per week of specific physiotherapy including exoskeleton exercises plus 5 sessions per week of conventional physiotherapy
Duration - Up to 5 weeks after intervention
Participants continue conventional physiotherapy and other usual care, with ongoing weekly assessments of balance, gait, motor function, and lateropulsion severity until week 8.
Weekly assessments
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Jeannine Bergmann, Carmen Krewer, Klaus Jahn...
https://pubmed.ncbi.nlm.nih.gov/30171076/Bernhard Baier, Julia Suchan, Hans-Otto Karnath...
https://pubmed.ncbi.nlm.nih.gov/22357719/Carolee J Winstein, Joel Stein, Ross Arena...
https://pubmed.ncbi.nlm.nih.gov/27145936/Carmen Krewer, Katrin Rieß, Jeannine Bergmann...
https://pubmed.ncbi.nlm.nih.gov/22889929/Ting-Hsuan Hsu, Chi-Lin Tsai, Ju-Yang Chi...
https://pubmed.ncbi.nlm.nih.gov/35525427/T Brandt, M Dieterich, A Danek
https://pubmed.ncbi.nlm.nih.gov/8154866/Julien Barra, Adélaïde Marquer, Roxane Joassin...
https://pubmed.ncbi.nlm.nih.gov/21097492/Dennis R Louie, W Ben Mortenson, Melanie Durocher...
https://pubmed.ncbi.nlm.nih.gov/34629104/Matteo Paci, Gabriele Macchioni, Francesco Ferrarello
https://pubmed.ncbi.nlm.nih.gov/35156566/M Dieterich, T Brandt
https://pubmed.ncbi.nlm.nih.gov/1586141/University Hospital, Grenoble
Lead Sponsor
Fondation pour la recherche sur les AVC
Collaborating Sponsor